Deep Dive: Oncology 2024
Join our exploration of vital oncology topics, including caring for cancer survivors, AI in patient care, the future of CAR-T therapies, and the rise of targeted radiopharmaceuticals. Plus, discover insights on prostate cancer disparities, the impact of open access on research, and advancements from ASCO 2024.
A history of: Mapping breast cancer’s journey from past to present
Join Deep Dive editor Eloise McLennan to explore the evolution of breast cancer research, from a mysterious malady in ancient Egypt to the discovery of genetic markers and precision medicine.
Life after cancer: Navigating survivorship and mental health
The treatment is done, but the story is just beginning. Pharmaphorum web editor Nicole Raleigh explores how cutting-edge research is transforming post-cancer care and helping survivors reclaim their lives with confidence.
Oncology trials: Top 5 trends to watch
Innovative designs, accelerated early-stage research, novel drug classes, advanced imaging, and personalised treatment optimisation are reshaping the oncology trial landscape, as Advanced Clinical's Dr Ravi Karra explains.
At ASCO, a focus on cancer care as well as cure
Pharmaphorum’s editor-in-chief Jonah Comstock highlights ASCO 2024's focus on evolving cancer care, with new guidelines promoting early palliative interventions to improve patient experiences throughout treatment.
Commercialisation in oncology: Challenges and innovative solutions for pharma manufacturers
Industry experts from EVERSANA outline how small and midsize pharma can overcome oncology commercialisation challenges through integrated data, strategic partnerships, and advanced tech for successful therapy launches.
Insider insights: viTToria CEO Nicholas Siciliano on the future of CAR-T
In an exclusive interview, viTToria Biotherapeutics' CEO Nicholas Siciliano delves into CAR-T therapy's current limitations, future possibilities, and the innovations needed to unlock its full therapeutic potential.
Transforming Oncology: The rise of targeted radiopharmaceuticals
Vikram Gosain from Putnam (an Inizio Advisory company) explores the transformative impact of targeted radiopharmaceuticals in cancer treatment, highlighting successes, emerging trends, and industry challenges.
Bridging the gap: Mitigating disparities in prostate cancer outcomes
Addressing stark racial and economic disparities in prostate cancer mortality requires a multifaceted approach focusing on improved screening methods, public awareness, and treatment affordability, as Dr Arnon Chait explains.
Heard on the pipeline: ASCO 2024
Pharmaphorum's Jonah Comstock polls ASCO 2024 attendees on their best advice for oncology newcomers, capturing insights on scientific prowess, collaborative spirit, and navigating cutting-edge clinical trials.
How AI and predictive analytics are set to transform patient care
Industry expert Rami Riman explores the integration of AI and predictive analytics in healthcare, highlighting their potential to boost diagnostic accuracy, treatment personalisation, and operational efficiency across various medical fields.
Inside the open access movement: Unleashing the potential of oncology research
Deep Dive editor Eloise McLennan unpacks the open access research movement in oncology, from its roots to its impact on accelerating discoveries and enhancing research integrity.
Read Deep Dive: Oncology in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.
